** Shares of Australia's Biosciences RHY.AX rise as much as 19.2% to A$0.28, their highest level since October 11, 2023
** On track for best week since late-March 2020, gaining 79.3% this week
** The medical diagnostics tech firm secured a multi-year commercial supply agreement executed with U.S.-based Quansys Biosciences for ColoSTAT reagent kit manufacturing on Tuesday
** About 3.1 million shares change hands, 3.4 times the 30-day avg
** Up 92.6% YTD
(Reporting by Anjali Singh in Bengaluru)
((anjali.singh2@thomsonreuters.com;))